SYMTUZA
SYMTUZA
Approved
DIN Number
02473720
Drug Class
Human
Market Date
Apr 25, 2018
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473720
AIG Number0460090001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR22 EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08
Health Canada Classification
ACTIVE INGREDIENTS (4)
COBICISTATActive
Strength: 150 MG
Monograph: COBICISTAT
DARUNAVIR (DARUNAVIR ETHANOLATE)Active
Strength: 800 MG
Monograph: DARUNAVIR (DARUNAVIR ETHANOLATE)
EMTRICITABINEActive
Strength: 200 MG
Monograph: EMTRICITABINE
TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE)Active
Strength: 10 MG
Monograph: TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE)